Medicilon

Medicilon is a professional CRO offering comprehensive preclinical R&D services for the biopharmaceutical industry, providing global pharmaceutical companies and research institutions with one-stop new drug R&D services that meet both domestic and international submission standards. The company’s services cover the entire process of preclinical new drug research, primarily including drug discovery, pharmaceutical research, and preclinical studies. Drug discovery R&D service projects include protein target validation, structural biology, chemical synthesis, compound activity screening, and optimization; pharmaceutical research includes API and formulation process research, quality standards, and stability studies; preclinical research encompasses pharmacodynamics, pharmacokinetics, toxicology, and safety evaluation studies. We focus on the innovative development needs of the global pharmaceutical industry, centering on key aspects of innovative drug R&D. Leveraging our experience in serving the domestic and international biopharmaceutical industries, we have built a comprehensive technical platform covering key technologies in drug discovery, pharmaceutical research, and preclinical research, providing the global biopharmaceutical industry with full-scale preclinical new drug R&D services.